AstraZeneca (AstraZeneca) Market Cap : $219,130 Mil (As of Apr. 25, 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AstraZeneca's share price for the quarter that ended in Dec. 2023 was $67.35. AstraZeneca's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 3,100 Mil. Therefore, AstraZeneca's market cap for the quarter that ended in Dec. 2023 was $208,807 Mil.

AstraZeneca's quarterly market cap declined from Jun. 2023 ($221,850 Mil) to Sep. 2023 ($209,919 Mil) and declined from Sep. 2023 ($209,919 Mil) to Dec. 2023 ($208,807 Mil).

AstraZeneca's annual market cap increased from Dec. 2021 ($180,505 Mil) to Dec. 2022 ($210,153 Mil) but then declined from Dec. 2022 ($210,153 Mil) to Dec. 2023 ($208,807 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AstraZeneca's Enterprise Value for Today is $238,480 Mil.

AstraZeneca Market Cap Historical Data

The historical data trend for AstraZeneca's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Market Cap Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

130,846.60

131,240.75

180,505.10

210,152.88

208,807.23

AstraZeneca Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															210,152.88	215,149.48	221,849.82	209,919.13	208,807.23

Competitive Comparison of AstraZeneca's Market Cap

For the Drug Manufacturers - General subindustry, AstraZeneca's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Market Cap distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Market Cap falls into.

AstraZeneca Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

AstraZeneca's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$67.35	*	3100.33
	=	$208,807

AstraZeneca's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	$67.35	*	3100.33
	=	$208,807

AstraZeneca (NAS:AZN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

AstraZeneca Market Cap Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.